A heart researcher who fabricated patient records for her studies on the blood pressure medication ramipril has earned her fourth retraction, and more are apparently on the way.
For readers who are new to this case: Things first unraveled for Anna Ahimastos when a subanalysis of a JAMA clinical trial revealed “anomalies,” triggering an investigation. After Ahimastos admitted to fabricating patient data, that JAMA paper and two others — including a small trial in Annals of Internal Medicine — were pulled. A spokesperson for her former employer, Baker IDI Heart & Diabetes Institute, told us last week that they have requested more retractions:
Five papers and one letter are in the process of being retracted.
The Annals and this latest paper are included in the five papers, so we expect to see Continue reading Heart researcher who faked patient data gets 4th retraction